FDA says migraine drug hikes the risk of oral birth defects | TheMedGuru
Links shared publicly online about this topic.
- 456total visits
FDA says migraine drug hikes the risk of oral birth defects | TheMedGuru
New data shows pregnant women taking the drug sold generically and by Johnson & Johnson as Topamax are around 20 times more likely to have their babies develop cleft lips or cleft palate deformities than those who are not taking the drug, the Food and Drug Administration (FDA) said. Warn pregnant patients about the risks
View full resource at themedguru.com
Tags: Migraine, Migraine Medication, Headache, Vascular Headache, Drug, Childbirth, FDA
Most Recently Shared on March 7, 2011 at 7:34 pm By:
#smartmothers FDA says migraine h/a meds can cause oral #birth defects http://dld.bz/QXff
Advertisement
